Patents Assigned to Alpex Pharma S.A.
  • Publication number: 20210128569
    Abstract: The present invention includes an orodispersible polyalcohol-free formulation containing vardenafil or a pharmaceutically acceptable salt thereof as active ingredient, as well as filler, a buffering agent, a lubricant, a sweetener, a flavoring agent and, optionally, further pharmaceutically acceptable excipients.
    Type: Application
    Filed: October 21, 2020
    Publication date: May 6, 2021
    Applicant: Alpex Pharma S.A.
    Inventors: Federico STROPPOLO, Gabriele GRANATA
  • Patent number: 10688121
    Abstract: The present invention relates to a granular composition for oral suspension characterized by the presence of an insoluble resin and a silica gel.
    Type: Grant
    Filed: July 28, 2016
    Date of Patent: June 23, 2020
    Assignee: ALPEX PHARMA S.A.
    Inventors: Federico Stroppolo, Gabriele Granata
  • Patent number: 10258693
    Abstract: Disclosed is a pharmaceutical composition in the form of a tablet suitable for dissolution in the buccal cavity, said composition comprising i) an effective amount of a narcotic active ingredient, and ii) a pharmaceutically acceptable amine having a pK of about 8 or greater, wherein the molar ratio of amine:active ingredient is at least about 5:1.
    Type: Grant
    Filed: September 4, 2013
    Date of Patent: April 16, 2019
    Assignee: ALPEX PHARMA S.A.
    Inventors: Federico Stroppolo, Shahbaz Ardalan
  • Patent number: 10245284
    Abstract: The present invention relates to a granular composition for oral suspension characterized by the presence of an insoluble resin and a silica gel.
    Type: Grant
    Filed: August 19, 2015
    Date of Patent: April 2, 2019
    Assignee: ALPEX PHARMA S.A.
    Inventors: Federico Stroppolo, Gabriele Granata
  • Patent number: 9561204
    Abstract: Effervescent pharmaceutical compositions containing a high amount of N-acetylcysteine and a method of treating acetaminophen poisoning with effervescent pharmaceutical compositions containing a high amount of N-acetylcysteine are described.
    Type: Grant
    Filed: July 28, 2016
    Date of Patent: February 7, 2017
    Assignee: ALPEX PHARMA S.A
    Inventors: Federico Stroppolo, Gabriele Granata, Shahbaz S. Ardalan
  • Patent number: 9480661
    Abstract: An orally disintegrating tablet which can be chewed or disintegrated by contact with saliva and containing weight-loss drugs for weight control in humans, especially in children and adolescents, is disclosed.
    Type: Grant
    Filed: February 21, 2008
    Date of Patent: November 1, 2016
    Assignee: Alpex Pharma S.A.
    Inventors: Federico Stroppolo, Shahbaz Ardalan
  • Patent number: 9427421
    Abstract: Effervescent pharmaceutical compositions containing a high amount of N-acetylcysteine and a method of treating acetaminophen poisoning with effervescent pharmaceutical compositions containing a high amount of N-acetylcysteine are described.
    Type: Grant
    Filed: July 15, 2015
    Date of Patent: August 30, 2016
    Assignee: ALPEX PHARMA S.A.
    Inventors: Federico Stroppolo, Gabriele Granata, Shahbaz S. Ardalan
  • Publication number: 20140234228
    Abstract: Effervescent pharmaceutical compositions containing a high amount of N-acetylcysteine and a method of treating acetaminophen poisoning with effervescent pharmaceutical compositions containing a high amount of N-acetylcysteine are described.
    Type: Application
    Filed: April 29, 2014
    Publication date: August 21, 2014
    Applicant: ALPEX PHARMA S.A.
    Inventors: Federico STROPPOLO, Gabriele Granata, Shahbaz S. Ardalan
  • Patent number: 8747894
    Abstract: Effervescent pharmaceutical compositions containing a high amount of N-acetylcysteine and a method of treating acetaminophen poisoning with effervescent pharmaceutical compositions containing a high amount of N-acetylcysteine are described.
    Type: Grant
    Filed: May 8, 2012
    Date of Patent: June 10, 2014
    Assignee: Alpex Pharma S.A.
    Inventors: Federico Stroppolo, Gabriele Granata, Shahbaz Ardalan
  • Publication number: 20140018392
    Abstract: Disclosed is a pharmaceutical composition in the form of a tablet suitable for dissolution in the buccal cavity, said composition comprising i) an effective amount of a narcotic active ingredient, and ii) a pharmaceutically acceptable amine having a pK of about 8 or greater, wherein the molar ratio of amine:active ingredient is at least about 5:1.
    Type: Application
    Filed: September 4, 2013
    Publication date: January 16, 2014
    Applicant: ALPEX PHARMA S.A.
    Inventors: Federico STROPPOLO, Shahbaz ARDALAN
  • Publication number: 20130302259
    Abstract: Effervescent pharmaceutical compositions containing a high amount of N-acetylcysteine and a method of treating acetaminophen poisoning with effervescent pharmaceutical compositions containing a high amount of N-acetylcysteine are described.
    Type: Application
    Filed: May 8, 2012
    Publication date: November 14, 2013
    Applicant: ALPEX PHARMA S.A.
    Inventors: Federico STROPPOLO, Gabriele GRANATA, SHAHBAZ ARDALAN
  • Patent number: 8574552
    Abstract: Disclosed is a pharmaceutical composition in the form of a tablet suitable for dissolution in the buccal cavity, said composition comprising i) an effective amount of a narcotic active ingredient, and ii) a pharmaceutically acceptable amine having a pK of about 8 or greater, wherein the molar ratio of amine:active ingredient is at least about 5:1.
    Type: Grant
    Filed: July 21, 2006
    Date of Patent: November 5, 2013
    Assignee: Alpex Pharma S.A.
    Inventors: Federico Stroppolo, Shahbaz Ardalan
  • Publication number: 20080206327
    Abstract: An orally disintegrating tablet which can be chewed or disintegrated by contact with saliva and containing weight-loss drugs for weight control in humans, especially in children and adolescents, is disclosed.
    Type: Application
    Filed: February 21, 2008
    Publication date: August 28, 2008
    Applicant: ALPEX PHARMA S.A.
    Inventors: Federico Stroppolo, Shahbaz Ardalan
  • Publication number: 20070020187
    Abstract: Disclosed is a pharmaceutical composition in the form of a tablet suitable for dissolution in the buccal cavity, said composition comprising i) an effective amount of a narcotic active ingredient, and ii) a pharmaceutically acceptable amine having a pK of about 8 or greater, wherein the molar ratio of amine:active ingredient is at least about 5:1.
    Type: Application
    Filed: July 21, 2006
    Publication date: January 25, 2007
    Applicant: ALPEX PHARMA S.A.
    Inventors: Federico Stroppolo, Shahbaz Ardalan
  • Publication number: 20070020186
    Abstract: The present invention provides solid dosage formulations of narcotic drugs with improved buccal adsorption. These improved characteristics are provided by the combination of the narcotic drug with an additional non-toxic soluble organic compound. The soluble organic compound contains a primary, secondary or tertiary amine group. The addition of this organic compound favorably alters the kinetics of mucosal penetration such that mucosal penetration times are decreased. This provides for a faster onset of action of the drug.
    Type: Application
    Filed: July 22, 2005
    Publication date: January 25, 2007
    Applicant: ALPEX PHARMA S.A.
    Inventors: Federico Stroppolo, Shahbaz Ardalan
  • Patent number: 7086408
    Abstract: The present invention relates to a multipurpose system for the automatic washing and drying of industrial containers and appliances, in controlled environmental conditions.
    Type: Grant
    Filed: November 11, 2004
    Date of Patent: August 8, 2006
    Assignee: Alpex Pharma S.A.
    Inventor: Federico Stroppolo